AR092570A1 - Composicion oral que contiene dapoxetina como base libre - Google Patents

Composicion oral que contiene dapoxetina como base libre

Info

Publication number
AR092570A1
AR092570A1 ARP130103296A ARP130103296A AR092570A1 AR 092570 A1 AR092570 A1 AR 092570A1 AR P130103296 A ARP130103296 A AR P130103296A AR P130103296 A ARP130103296 A AR P130103296A AR 092570 A1 AR092570 A1 AR 092570A1
Authority
AR
Argentina
Prior art keywords
free base
composition containing
oral composition
dapoxetine
containing dapoxetine
Prior art date
Application number
ARP130103296A
Other languages
English (en)
Inventor
Jeon Hong
Ryeol - Cha Bong
Geun - Kim Jun
Ki - Park Su
Jun - Lee Bong-Sang
Original Assignee
Ctc Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ctc Bio Inc filed Critical Ctc Bio Inc
Publication of AR092570A1 publication Critical patent/AR092570A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una forma farmacéutica que se administra disolviendo o desintegrando por vía oral, especialmente aquella en forma de film, que se caracteriza por sus componentes válidos de dapoxetina como base libre y que contiene dapoxetina o sal farmacéuticamente aceptable de la misma.
ARP130103296A 2012-09-13 2013-09-13 Composicion oral que contiene dapoxetina como base libre AR092570A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20120101772 2012-09-13

Publications (1)

Publication Number Publication Date
AR092570A1 true AR092570A1 (es) 2015-04-22

Family

ID=50278454

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130103296A AR092570A1 (es) 2012-09-13 2013-09-13 Composicion oral que contiene dapoxetina como base libre

Country Status (3)

Country Link
AR (1) AR092570A1 (es)
TW (1) TW201422224A (es)
WO (1) WO2014042416A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1225881T1 (sl) * 1999-09-03 2006-06-30 Apbi Holdings Llc Uporaba dapoksetina, selektivnega zaviralca ponovnega privzema serotonina s hitrim pricetkom delovanja, za zdravljenje seksualne disfunkcije
WO2008035358A2 (en) * 2006-06-05 2008-03-27 Cadila Healthcare Limited Process for preparing dapoxetine
JP5395663B2 (ja) * 2006-08-14 2014-01-22 ニューロヒーリング・ファーマシューティカルズ・インコーポレーテッド モダフィニルによる早漏の治療
KR20120068678A (ko) * 2010-09-17 2012-06-27 에스케이케미칼주식회사 (ｓ)-ｎ,ｎ-디메틸-3-(나프탈렌-1-일옥시)-1-페닐프로판-1-아민 유도체, 이를 포함하는 약학 조성물 및 이의 제조 방법
WO2012053006A2 (en) * 2010-10-18 2012-04-26 Panacea Biotec Ltd Improved oral fast dissolving films comprising combination of polymers and method of preparation thereof

Also Published As

Publication number Publication date
TW201422224A (zh) 2014-06-16
WO2014042416A1 (ko) 2014-03-20

Similar Documents

Publication Publication Date Title
FR2959935B1 (fr) Forme pharmaceutique orale alcoolo-resistante
HUE053776T2 (hu) Gyógyszerészeti készítmény, amely helyi érzéstelenítõként bupivakaint tartalmaz szájban vagy torokban történõ helyi adagoláshoz
JP2013014622A5 (es)
GT201500053A (es) Composicion farmaceutica recubierta que contiene regorafenib
ECSP14013169A (es) Tableta a prueba de alteración que proporciona liberación inmediata del fármaco
IT1400982B1 (it) Collirio osmotico trans-epiteliale per la cura del cheratocono.
CL2014001016A1 (es) Compuestos triciclicos condensados y sus sales farmaceuticamente aceptables; composicion farmaceutica que los comprende; y su uso en el tratamiento de una infeccion viral.
GT201200284A (es) Composición farmacéutica
BR112014020992A2 (pt) Composto,uso de composto na fabricação de um medicamento e composição farmacêutica
UA115811C2 (uk) Стабільний розчин об'єднаних баклофену, сорбіту і налтрексону для перорального застосування
AR088297A1 (es) R(+)-n-formil-propargil-aminoindano
GT201200304A (es) Composiciones farmacéuticas que comprenden hidromorfona y naloxona
CO6920289A2 (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib.
AR092151A1 (es) Preparacion farmaceutica solida que contiene levotiroxina
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
ECSP15030460A (es) Composición de difenidol de liberación prolongada
CU20140028A7 (es) Compuesto de benzotiazolona
CL2014003484A1 (es) Uso de nalmefeno en la reduccion del consumo de alcohol en un paciente con dependencia del alcohol; composicion farmaceutica oral; combinacion farmaceutica.
PE20151282A1 (es) Combinacion de medicamentos que comprenden fenilefrina y paracetamol
AR092570A1 (es) Composicion oral que contiene dapoxetina como base libre
UY33789A (es) Combinación que comprende un derivado de la familia de las combretastatinas y cetuximab
CL2008003711A1 (es) Proceso para preparar una forma de dosificación farmaceutica que comprende florfenicol o un análogo de este; y para recuperar florfenicol o un análogo de una composición farmacéutica.
CL2014002203A1 (es) Uso de modafinilo en el tratamiento de sustitucion de cocainomanos; composicion farmaceutica oral que contiene modafinilo en la forma de su enantiomero dextrogiro.
EA201590732A1 (ru) Диспергируемая таблетка
PE20141411A1 (es) Nueva forma de cristal

Legal Events

Date Code Title Description
FB Suspension of granting procedure